1. miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition
   Siti A. Sulaiman et al, 2016, Front. Pharmacol. CrossRef
2. The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer.
   Chen Weingarten et al, 2018, Horm Cancer CrossRef
3. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites—Correlation of tissue microarray and cytology microarray
   Laszlo Toth et al, 2018, Pathology - Research and Practice CrossRef
4. Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
   Pawel Sadlecki et al, 2018, Tumour Biol. CrossRef
5. VIMENTIN EXPRESSION IN HUMAN CELL LINES OF EPITHELIAL TUMORS
   T. A. Bogush et al, 2018, Usp. mol. onkol CrossRef
6. BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop
   Qianyun Zhang et al, 2018, Chemico-Biological Interactions CrossRef
7. Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells
   Majid Momeny et al, 2018, Anti-Cancer Drugs CrossRef
8. Quantitative assesment of coexpression of cytokeratins and mesenchimal cells marker vimentin in serous ovarian cancer
   T. A. Bogush et al, 2017, Rossijskij bioterapevtičeskij žurnal CrossRef
9. Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
   Lili Lu et al, 2016, Cancer Med CrossRef
10. Epithelial-mesenchymal plasticity in circulating tumor cells
    Catherine Alix-Panabières et al, 2017, J Mol Med CrossRef
11. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
    Edward Geeurickx et al, 2019, Molecular Aspects of Medicine CrossRef
12. Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines
    T. A. Bogush et al, 2019, Moscow Univ. Chem. Bull. CrossRef
13. Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells
    Yoshihiro Koya et al, 2018, Oncotarget CrossRef
14. Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
    Daisuke Fukagawa et al, 2018, Oncotarget CrossRef
15. Expression of and correlation between BCL6 and ZEB family members in patients with breast cancer
    Lin Ang et al, 2017, Exp Ther Med CrossRef
16. Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
    Rosanna Sestito et al, 2020, Commun Biol CrossRef
17. Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer
    Karolina Seborova et al, 2021, Cancers CrossRef
18. null
    Khalid El Bairi et al, 2021 CrossRef
19. GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
    Yong Feng et al, 2022, CMAR CrossRef
20. null
    Yoichi Robertus Fujii, 2022 CrossRef
21. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer
    Yiqun Li et al, 2022, Genes CrossRef
22. E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer
    Michal Kielbik et al, 2022, IJMS CrossRef
23. miR‐200a‐3p regulates epithelial–mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway
    Yisha Wu et al, 2024, Int Forum Allergy Rhinol CrossRef